# Cynerio Israel

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cynerio-israel

- Industry: Software
- Headquarters: Israel
- Website: https://www.cynerio.com/uk
- Total disclosed funding: $37M
- Latest round: Series B (May 19, 2021)
- Investors on record: 5

## About

Based in Israel and founded in 2017, Cynerio Israel Ltd. is a cybersecurity company for healthcare IoT devices. Leon Lerman (CEO) and Daniel Brodie (CTO) are the founders of the company. In May 2021, the company raised USD 30 million in series B funding led by new investor ALIVE, with participation from returning investors Accelmed, Consensus Business Group, MTIP, RDC, and an unspecified investor.

The company offers a healthcare IoT cybersecurity platform that protects every connected device including medical/IoMT, Enterprise IoT, or an OT system, and every threat vector. The platform provides solutions for all IoT devices, medical devices, and business needs: Information security solutions; biomedical engineering solutions, and executive management solutions. This platform also provides device behavior learning with medical workflow analysis understanding their associated risks and protect against harmful cyber-attacks. The company serves hospitals, clinics, and medical institutions.

The company plans to expand its channel program, accelerate technological development, enhance support to existing customers, and reinforce its position in North America.

## Funding rounds

- Series B, May 19, 2021, $30M — Consensus Business Group, Accelmed, MTIP, ALIVE, Elron Ventures
- Seed, Jun 1, 2018, $7M — Accelmed, MTIP, Elron Ventures

## Investors

- Accelmed (https://capitalatlas.ai/funds/accelmed) — Seed, Series B
- MTIP (https://capitalatlas.ai/funds/mtip) — Seed, Series B
- Elron Ventures (https://capitalatlas.ai/funds/elron-ventures) — Seed, Series B
- Consensus Business Group — Series B
- ALIVE — Series B